These data provide further evidence that T2DM-associated polymorphisms in the SLC30A8 gene may act in part via alterations in glucagon release and suggest that ZnT8 activation may restrict glucagon release in some settings. Here, SLC30A8 is linked to type 2 diabetes mellitus.